サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1738509

医療用マイクロ流体デバイスの世界市場規模：タイプ別、用途別、材料別、エンドユーザー別、地域範囲別および予測

Global Medical Microfluidic Devices Market Size By Type, By Application, By Material, By End-User, By Geographic Scope and Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
医療用マイクロ流体デバイスの世界市場規模：タイプ別、用途別、材料別、エンドユーザー別、地域範囲別および予測
出版日: 2025年05月12日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療用マイクロ流体デバイスの市場規模と予測

医療用マイクロ流体デバイス市場規模は、2024年に145億8,000万米ドルと評価され、2026～2032年にかけてCAGR 19.97%で成長し、2032年には551億9,000万米ドルに達すると予測されています。

  • 医療用マイクロ流体デバイスは、微小体積の流体を操作するために設計された小規模なシステムであり、通常は診断、治療、分析の目的で使用されます。
  • これらのデバイスは、ポイントオブケア診断、ドラッグデリバリー、ラボオンチップ技術などの用途に広く使用されています。迅速で正確、かつ費用対効果の高い検査を提供するその能力は、病気の早期発見や個別化治療を可能にし、ヘルスケアに革命をもたらしました。
  • 医療用マイクロ流体デバイスの将来は有望であり、精密医療、ウェアラブルヘルスモニタリング、統合バイオセンサなどのセグメントでの進歩が期待され、患者の転帰をさらに向上させ、ヘルスケアプロセスを世界的に合理化します。

医療用マイクロ流体デバイスの世界市場力学

世界の医療用マイクロ流体デバイス市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

  • 慢性疾患の有病率の上昇：糖尿病やがんなどの慢性疾患の増加により、先進的診断ツールに対する需要が高まっています。世界保健機関（WHO）によると、糖尿病は全世界で4億2,200万人以上が罹患しており、マイクロ流体デバイスが得意とするポイントオブケア診断に対する大きなニーズが生まれている
  • ヘルスケア・イノベーションに対する政府の支援：様々な政府がヘルスケアの研究とイノベーションにインセンティブと資金を提供しています。例えば、米国国立衛生ラボ（NIH）は2023年に医療研究に390億米ドルを割り当て、早期診断や個別化医療に向けたマイクロ流体デバイスの研究開発を支援しています。
  • ポイントオブケア検査（POCT）の需要増加：迅速かつ正確な検査結果を提供するPOCTは、その利便性から人気が高まっています。米国疾病予防管理センター（CDC）の報告書によると、世界のPOCT市場は年率10％の成長が見込まれており、マイクロ流体デバイスの採用をさらに促進しています。
  • ラボオンチップデバイスの技術的進歩：ラボオンチップシステムの継続的な技術進歩により、診断やドラッグデリバリーへの応用が拡大しています。こうした技術革新は、大型の実験装置の必要性を減らし、コンパクトで持ち運び可能な代替品を提供するため、市場の成長を後押ししています。

主要課題

  • 複雑な製造プロセス：マイクロ流体デバイスの製造には、マイクロ流路を通る流体の流れを正確に制御する必要があるため、複雑なエンジニアリングが必要となります。この複雑さゆえに、ガラスやポリマーのような特殊な材料の使用、ソフトリソグラフィーのような先進的製造技術、クリーンルーム環境などがしばしば要求されます。こうした厳しい要件は製造コストとリードタイムを増加させ、製造の拡大性を制限し、中小企業の市場参入を困難にしています。
  • 規制上のハードル：マイクロ流体を含む医療機器は、診断や患者ケアにおいて重要な役割を果たすため、規制当局の承認プロセスは特に厳しいです。米国食品医薬品局（FDA）と欧州医薬品庁（EMA）は、安全性と有効性を確保するために厳しい検査と認証基準を課しています。これらのプロセスには時間とコストがかかるため、革新的な製品の市場投入に遅れが生じ、技術導入のペースを妨げています。
  • 開発途上地域での認知度の低さ：マイクロ流体デバイスの可能性が高まっているにもかかわらず、その採用は主に市場に集中しています。開発途上地域では、認知度の低さ、不十分なヘルスケアインフラ、最先端技術へのアクセスの制限などが大きな課題となっています。さらに、これらの地域のヘルスケアプロバイダは費用対効果の高いソリューションを優先するため、高価と思われがちな先端診断機器への需要が制限される可能性があります。
  • 高い開発コスト：マイクロ流体デバイスの開発には、精度と信頼性を確保するための広範な研究、プロトタイピング、検査が含まれます。そのため、技術面でも熟練した人材面でも、多額の資本投資が必要となります。新興企業や中小企業は、こうしたデバイスの開発に必要な資金を確保する上で課題に直面する可能性があります。

主要動向

  • ウェアラブル健康機器との統合：マイクロ流体デバイス市場の重要な動向は、ウェアラブルヘルス技術との統合です。マイクロ流体センサをウェアラブル機器に組み込むことで、グルコースレベル、水分補給状態、電解質バランスなど、さまざまな生理学的パラメーターを追跡することができます。この統合により、患者、特に糖尿病のような慢性疾患を持つ患者のリアルタイムモニタリングが可能になり、患者ケアを強化し、早期診断と予防ヘルスケアに新たな可能性を記載しています。
  • 個別化医療：個別化医療は、遺伝的、環境的、ライフスタイル的要因に基づいて個々の患者に合わせた治療を行うもので、マイクロ流体デバイスの需要を牽引しています。これらのデバイスは迅速な遺伝子・生化学分析を可能にし、臨床医に治療決定の指針となるリアルタイムのデータを記載しています。例えば、マイクロ流体工学は、患者固有の組織環境をモデル化する臓器オンチップシステムの作成に使用することができ、研究者は、異なる薬剤が特定の個人の状態にどのような影響を与えるかをテストすることができます。
  • プロトタイピングと製造のための3Dプリンティングの進歩：3Dプリンティング技術の使用は、マイクロ流体デバイスの設計と製造を一変させました。3Dプリンティングは、複雑なマイクロ流路設計の迅速なプロトタイピングを可能にし、機能的デバイスの開発にかかる時間とコストを削減します。この動向は、より革新的なデバイス構成につながり、研究者やメーカーは、デバイスの性能を高める新しい材料や構造を試すことができます。
  • 在宅ヘルスケアの拡大：遠隔医療と在宅ヘルスケアサービスの拡大が、使いやすく携帯可能な診断機器の需要を促進しています。最小限のサンプル量で複雑な診断テストを実行できるマイクロ流体デバイスは、家庭用に適応されるケースが増えています。これらの機器は、患者が自宅にいながらにして慢性疾患のモニタリングや日常的な健康チェックを行うためのポイントオブケア検査キットに組み込まれています。

目次

第1章 医療用マイクロ流体デバイスの世界市場導入

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 医療用マイクロ流体デバイスの世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 医療用マイクロ流体デバイスの世界市場：タイプ別

  • 概要
  • チップ
  • センサ
  • ポンプ
  • バルブ
  • ニードル
  • ミキサー
  • リアクタ
  • セパレーター

第6章 医療用マイクロ流体デバイスの世界市場：用途別

  • 概要
  • 診断用デバイス
  • 治療用デバイス
  • 研究用デバイス
  • 臨床検査用デバイス

第7章 医療用マイクロ流体デバイスの世界市場：材料別

  • 概要
  • ガラス
  • ポリマー
  • シリコン
  • 金属
  • セラミック

第8章 医療用マイクロ流体デバイスの世界市場：エンドユーザー別

  • 概要
  • 病院クリニック
  • 診断ラボ
  • 製薬・バイオテクノロジー企業
  • ラボ・学術機関

第9章 医療用マイクロ流体デバイスの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • その他
    • ラテンアメリカ
    • 中東・アフリカ

第10章 世界の医療用マイクロ流体デバイス市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主要開発戦略

第11章 企業プロファイル

  • Abbott Laboratories
  • Agilent Technologies
  • Siemens
  • BIO-RAD Laboratories
  • Raindance Technologies Inc.
  • Micronit Microtechnologies
  • Dolomite Microfluids
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • BioMerieux.

第12章 主要開発

  • 製品の上市/開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第13章 付録

  • 関連調査
目次
Product Code: 59336

Medical Microfluidic Devices Market Size and Forecast

Medical Microfluidic Devices Market size was valued at USD 14.58 Billion in 2024 and is projected to reach USD 55.19 Billion by 2032, growing at a CAGR of 19.97% from 2026 to 2032.

  • Medical microfluidic devices are small-scale systems designed to manipulate tiny volumes of fluids, typically for diagnostic, therapeutic, or analytical purposes.
  • These devices are widely used in applications such as point-of-care diagnostics, drug delivery, and lab-on-a-chip technologies. Their ability to provide rapid, accurate, and cost-effective testing has revolutionized healthcare by enabling early disease detection and personalized treatments.
  • The future of medical microfluidics is promising, with advancements expected in areas like precision medicine, wearable health monitoring, and integrated biosensors, further enhancing patient outcomes and streamlining healthcare processes globally.

Global Medical Microfluidic Devices Market Dynamics

The key market dynamics that are shaping the global medical microfluidic devices market include:

Key Market Drivers

  • Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions such as diabetes and cancer are driving demand for advanced diagnostic tools. According to the World Health Organization (WHO), diabetes affects over 422 million people globally, creating a significant need for point-of-care diagnostics, which microfluidic devices excel at delivering.
  • Government Support for Healthcare Innovation: Various governments are providing incentives and funding for healthcare research and innovation. For example, the U.S. National Institutes of Health (NIH) allocated $39 billion in 2023 for medical research, supporting the development of microfluidic devices for early diagnosis and personalized medicine.
  • Increasing Demand for Point-of-Care Testing (POCT): Point-of-care diagnostics, which provide rapid and accurate test results, are becoming more popular due to the convenience they offer. According to a report by the Centers for Disease Control and Prevention (CDC), the global POCT market is expected to grow by 10% annually, further driving the adoption of microfluidic devices.
  • Technological Advancements in Lab-on-a-Chip Devices: Continuous technological advancements in lab-on-a-chip systems have expanded their application in diagnostics and drug delivery. These innovations reduce the need for large laboratory equipment, offering a compact and portable alternative, thus driving market growth.

Key Challenges

  • Complex Manufacturing Processes: The production of microfluidic devices involves intricate engineering, as they require precise control over the fluid flow through microchannels. This complexity often demands the use of specialized materials like glass or polymers, advanced fabrication techniques such as soft lithography, and cleanroom environments. These stringent requirements increase production costs and lead times, limiting the scalability of manufacturing and making it difficult for smaller companies to enter the market.
  • Regulatory Hurdles: Regulatory approval processes are particularly stringent for medical devices, including microfluidics, due to their critical role in diagnostics and patient care. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose rigorous testing and certification standards to ensure safety and efficacy. These processes can be time-consuming and costly, creating delays in bringing innovative products to the market and hindering the pace of technological adoption.
  • Limited Awareness in Developing Regions: Despite the growing potential of microfluidic devices, their adoption is primarily concentrated in developed markets. In developing regions, lack of awareness, inadequate healthcare infrastructure, and limited access to cutting-edge technologies pose significant challenges. Furthermore, healthcare providers in these regions may prioritize cost-effective solutions, limiting the demand for advanced diagnostic devices that can be perceived as expensive.
  • High Development Costs: Developing microfluidic devices involves extensive research, prototyping, and testing to ensure precision and reliability. This requires significant capital investment, both in terms of technology and skilled personnel. Startups and smaller enterprises may face challenges in securing the necessary funding to develop these devices

Key Trends

  • Integration with Wearable Health Devices: A significant trend in the microfluidic devices market is their integration with wearable health technologies. Microfluidic sensors can be embedded in wearable devices to track various physiological parameters, such as glucose levels, hydration status, and electrolyte balance. This integration enables real-time monitoring of patients, particularly those with chronic conditions like diabetes, enhancing patient care and offering new possibilities for early diagnosis and preventative healthcare.
  • Personalized Medicine: Personalized medicine, which tailors' treatments to individual patients based on genetic, environmental, and lifestyle factors, is driving the demand for microfluidic devices. These devices enable rapid genetic and biochemical analyses, providing clinicians with real-time data to guide treatment decisions. For example, microfluidics can be used to create organ-on-a-chip systems that model patient-specific tissue environments, allowing researchers to test how different drugs will affect a particular individual's condition.
  • Advances in 3D Printing for Prototyping and Manufacturing: The use of 3D printing technology has transformed the design and production of microfluidic devices. 3D printing allows for the rapid prototyping of intricate microchannel designs, reducing the time and cost of developing functional devices. This trend is leading to more innovative device configurations, enabling researchers and manufacturers to experiment with new materials and structures that enhance device performance.
  • Expansion of Home Healthcare: The growth of telemedicine and home healthcare services is driving the demand for easy-to-use, portable diagnostic devices. Microfluidic devices, which can perform complex diagnostic tests with minimal sample volumes, are increasingly being adapted for home use. These devices are being integrated into point-of-care testing kits that patients can use to monitor chronic diseases or perform routine health checks from the comfort of their homes.

Global Medical Microfluidic Devices Market Regional Analysis

Here is a more detailed regional analysis of the global medical microfluidic devices market:

North America

  • North America holds the dominant position in the global medical microfluidic devices market, driven by its advanced healthcare infrastructure, strong research and development capabilities, and early adoption of cutting-edge medical technologies. The United States, in particular, plays a significant role due to its substantial investments in biotechnology and healthcare innovation. The region benefits from the presence of key market players and collaborative efforts between industry and academic institutions to develop advanced microfluidic solutions. According to the National Institutes of Health (NIH), U.S. government spending on biomedical research reached $45 billion in 2023, which has accelerated advancements in microfluidic devices.
  • Additionally, North America's regulatory framework is conducive to the rapid commercialization of new medical technologies, further driving market growth. The demand for point-of-care diagnostics, personalized medicine, and minimally invasive procedures is increasing, all of which rely heavily on microfluidic devices. The growing prevalence of chronic diseases, such as diabetes and cardiovascular disorders, is also fueling the adoption of these devices. In 2023, the U.S. Food and Drug Administration (FDA) approved several innovative microfluidic-based diagnostic tools, bolstering market leadership in the region.

Asia Pacific

  • Asia Pacific is the fastest-growing region in the global medical microfluidic devices market, driven by rapid advancements in healthcare infrastructure, increased government investments in biotechnology, and rising demand for affordable, point-of-care diagnostic tools. Countries like China, Japan, and South Korea are leading the charge in adopting microfluidic devices, particularly in diagnostics and drug delivery systems. China's healthcare market is expanding rapidly, and in 2023, the Chinese government announced a $15 billion initiative to boost research in medical technologies, including microfluidics, further accelerating market growth.
  • Additionally, the rising prevalence of chronic diseases and a growing aging population are key factors driving the demand for microfluidic devices in the region. The cost-effectiveness and efficiency of these devices make them appealing in the Asia Pacific market, where access to affordable healthcare solutions is a critical concern. India, too, is emerging as a key player in this sector, with startups and research institutions contributing to the development of low-cost microfluidic diagnostic devices. In 2023, Asia Pacific's microfluidic devices market grew by over 20%, making it the fastest-growing region globally.

Global Medical Microfluidic Devices Market: Segmentation Analysis

The Global Medical Microfluidic Devices Market is segmented on the basis of By Type, By Application, By Material, By End User and By Geography.

Medical Microfluidic Devices Market, By Type

  • Chips
  • Sensors
  • Pumps
  • Valves
  • Needles
  • Mixers
  • Reactors
  • Separators

Based on Type, the Global Medical Microfluidic Devices Market is segmented into Chips, Sensors, Pumps, Valves, Needles, Mixers, Reactors, and Separators. Chips represent the dominant segment due to their widespread use in lab-on-a-chip applications and point-of-care diagnostics. On the other hand, sensors are the fastest-growing segment, driven by the increasing demand for real-time monitoring in wearable health devices and personalized medicine.

Medical Microfluidic Devices Market, By Application

  • Diagnostic Devices
  • Therapeutic Devices
  • Research Devices
  • Clinical Testing Devices

Based on Application, the Global Medical Microfluidic Devices Market is segmented into Diagnostic Devices, Therapeutic Devices, Research Devices, and Clinical Testing Devices. The diagnostic devices segment is the dominant category in the medical microfluidic devices market, primarily driven by the growing demand for point-of-care testing and rapid diagnostic tools for diseases like diabetes, cardiovascular conditions, and infectious diseases. Meanwhile, the therapeutic devices segment is the fastest-growing, fueled by advancements in drug delivery systems and lab-on-a-chip technologies that enable targeted and efficient therapies, particularly for cancer treatment and precision medicine applications.

Medical Microfluidic Devices Market, By Material

  • Glass
  • Polymer
  • Silicon
  • Metals
  • Ceramics

Based on Material, the Global Medical Microfluidic Devices Market is segmented into Glass, Polymer, Silicon, Metals, and Ceramics. Polymer-Based Microfluidic Devices dominate due to their cost-effectiveness, ease of fabrication, and suitability for mass production. Polymers, such as polydimethylsiloxane (PDMS), are widely used because they offer flexibility, biocompatibility, and can be easily molded into intricate designs, making them ideal for disposable diagnostic applications. On the other hand, silicon-based microfluidic devices are the fastest-growing segment. Silicon offers high precision and thermal stability, making it ideal for advanced applications like lab-on-a-chip technologies and drug delivery systems, driving its rapid adoption in high-performance medical devices.

Medical Microfluidic Devices Market, By End-Users

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories & Academic Institutes

Based on End User, the Global Medical Microfluidic Devices Market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Laboratories & Academic Institutes. The hospitals and clinics segment dominates the medical microfluidic devices market, driven by the high demand for point-of-care diagnostics and the increasing need for rapid, accurate testing in clinical settings. However, the diagnostic laboratories segment is the fastest-growing, fueled by the growing adoption of advanced diagnostic tools for disease detection and monitoring.

Medical Microfluidic Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Medical Microfluidic Devices Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America holds the dominant position, driven by its advanced healthcare infrastructure, strong research and development capabilities, and early adoption of cutting-edge medical technologies. Asia Pacific is the fastest-growing region in the global medical microfluidic devices market, driven by rapid advancements in healthcare infrastructure, increased government investments in biotechnology, and rising demand for affordable, point-of-care diagnostic tools.

Key Players

The "Global Medical Microfluidic Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market Abbott Laboratories, Agilent Technologies, Siemens, BIO-RAD Laboratories, Raindance Technologies Inc., Micronit Microtechnologies, Dolomite Microfluids, Thermo Fisher Scientific Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Global Medical Microfluidic Devices Market: Recent Developments
  • In August 2024 Agilent Technologies announced the expansion of its microfluidics manufacturing capabilities by opening a new facility in California. This development aims to meet the rising demand for precision microfluidic devices used in diagnostic applications, ensuring faster production and enhanced product availability.
  • In July 2024 Fluidigm Corporation entered into a strategic collaboration with Thermo Fisher Scientific to integrate microfluidic technology with advanced genomic solutions. The partnership focuses on developing next-generation diagnostic platforms for cancer and infectious diseases, enhancing the capabilities of microfluidic devices in molecular diagnostics.
  • In June 2024 Dolomite Microfluidics launched a new high-throughput droplet generation system aimed at improving drug screening and diagnostics. This system is designed to accelerate research in personalized medicine, offering precise control over droplet size and enhanced throughput for clinical testing applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Chips
  • 5.3 Sensors
  • 5.4 Pumps
  • 5.5 Valves
  • 5.6 Needles
  • 5.7 Mixers
  • 5.8 Reactors
  • 5.9 Separators

6 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Diagnostic Devices
  • 6.3 Therapeutic Devices
  • 6.4 Research Devices
  • 6.5 Clinical Testing Devices

7 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY MATERIAL

  • 7.1 Overview
  • 7.2 Glass
  • 7.3 Polymer
  • 7.4 Silicon
  • 7.5 Metals
  • 7.6 Ceramics

8 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY END-USERS

  • 8.1 Overview
  • 8.2 Hospitals & Clinics
  • 8.3 Diagnostic Laboratories
  • 8.4 Pharmaceutical & Biotechnology Companies
  • 8.5 Research Laboratories & Academic Institutes

9 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East & Africa

10 GLOBAL MEDICAL MICROFLUIDIC DEVICES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Abbott Laboratories
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Agilent Technologies
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Siemens
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 BIO-RAD Laboratories
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Raindance Technologies Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Micronit Microtechnologies
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Dolomite Microfluids
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Thermo Fisher Scientific Inc.
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Illumina Inc.
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 BioMerieux.
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research